Polyarginine-modified liposome having nuclear entry ability
With the object of providing a liposome having cellular and nuclear entry ability, to achieve this object, a liposome is provided having on its surface a peptide comprising multiple consecutive arginine residues, and specifically a liposome is provided wherein the peptide is modified with a hydrophobic group or hydrophobic compound and the hydrophobic group or hydrophobic compound is inserted into a lipid bilayer so that the peptide is exposed on the surface of the bilayer.
1. A liposome for delivery of a target substance into cells, the liposome having one or more lipid bilayers,
wherein each lipid bilayer comprises an inner and outer surface,
wherein the inner and outer surface of each lipid bilayer consists of a single type of peptide,
wherein the peptide consists of 7 to 10 consecutive arginine residues,
wherein the peptide is modified with a hydrophobic group selected from the group consisting of saturated or unsaturated fatty acids capable of being inserted into said lipid bilayer consisting of noncationic lipids,
wherein the hydrophobic group is inserted into each lipid bilayer so that the peptide is exposed on the inner and outer surface of the lipid bilayer, and
wherein the amount of the modified peptide is 2% or more (molar ratio) of the total lipids making up each lipid bilayer.
2. The liposome according to claim 1 , wherein the peptide consists of 8 consecutive arginine residues.
3. The liposome according to claim 1 , wherein the hydrophobic group is a stearyl group.
4. The liposome according to claim 1 , wherein is entrapped a target substance to be delivered inside a cell or nucleus.
5. The liposome according to claim 4 , wherein the target substance is a drug, nucleic acid, peptide, protein or sugar or a complex thereof.
6. The liposome according to claim 5 , wherein the target substance is a nucleic acid molecule, and wherein a complex of the nucleic acid molecule and a polycationic substance it entrapped.
7. The liposome according to claim 5 , wherein the polycationic substance is stearylated polyarginine.
8. The liposome according to any of claims 4 through 7 , which is a vector for delivery of the target substance into cells.
9. The liposome according to any of claims 4 through 7 , which is a vector for delivery of the target substance into nuclei.
10. A liposome for delivery of a target substance into cells, the target substance being entrapped within the liposome and being a complex of a nucleic acid molecule and stearylated polyarginine, the liposome further having one or more lipid bilayers,
wherein each lipid bilayer comprises an inner and outer surface,
wherein the inner and outer surface of each lipid bilayer consists of a single type of peptide,
wherein the peptide consists of 7 to 10 consecutive arginine residues,
wherein the peptide is modified with a hydrophobic group selected from the group consisting of saturated or unsaturated fatty acids capable of being inserted into said lipid bilayer consisting of noncationic lipids,
wherein the hydrophobic group is inserted into each lipid bilayer so that the peptide is exposed on the inner and outer surface of the lipid bilayer, and
wherein the amount of the modified peptide is 2% or more (molar ratio) of the total lipids making up each lipid bilayer.
11. The liposome of claim 1 wherein the amount of the modified peptide is no greater than 30% (molar ratio) of the total lipids making up the lipid bilayer.
12. A modified liposome for delivery of a target substance into cells by macropinocytosis consisting of:
a liposome having one or more lipid bilayers,
wherein each lipid bilayer comprises an inner and outer surface,
wherein the inner and outer surface of each lipid bilayer consists of a single type of peptide,
wherein the peptide consists of 7 to 10 consecutive arginine residues,
wherein the peptide is modified with a hydrophobic group selected from the group consisting of saturated or unsaturated fatty acids capable of being inserted into said lipid bilayer consisting of noncationic lipids,
wherein the hydrophobic group is inserted into each lipid bilayer so that the peptide is exposed on the inner and outer surface of the lipid bilayer, and
wherein the amount of the modified peptide is 2% or more (molar ratio) of the total lipids making up each lipid bilayer.
13. The liposome of claim 12 wherein the amount of the modified peptide is no greater than 30% (molar ratio) of the total lipids making up the lipid bilayer.